Cholinergic Agents

"Cholinergic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Any drug used for its actions on cholinergic systems. Included here are agonists and antagonists, drugs that affect the life cycle of ACETYLCHOLINE, and drugs that affect the survival of cholinergic neurons. The term cholinergic agents is sometimes still used in the narrower sense of MUSCARINIC AGONISTS, although most modern texts discourage that usage.

Descriptor ID	D018678
MeSH Number(s)	D27.505.519.625.120 D27.505.696.577.120
Concept/Terms	Cholinergic Agents Cholinergic Agents Agents, Cholinergic Cholinergics Acetylcholine Agents Agents, Acetylcholine Cholinergic Drugs Drugs, Cholinergic Cholinomimetics Cholinomimetics Muscarinic Agents Muscarinic Agents Agents, Muscarinic Muscarinics Nicotinic Agents Nicotinic Agents Agents, Nicotinic Nicotinic Effect Nicotinic Effect Effect, Nicotinic Nicotinic Effects Effects, Nicotinic Cholinergic Effect Cholinergic Effect Effect, Cholinergic Cholinergic Effects Effects, Cholinergic Muscarinic Effect Muscarinic Effect Effect, Muscarinic Muscarinic Effects Effects, Muscarinic

Below are MeSH descriptors whose meaning is more general than "Cholinergic Agents".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Molecular Mechanisms of Pharmacological Action [D27.505.519]
Neurotransmitter Agents [D27.505.519.625]
Cholinergic Agents [D27.505.519.625.120]
Physiological Effects of Drugs [D27.505.696]
Neurotransmitter Agents [D27.505.696.577]
Cholinergic Agents [D27.505.696.577.120]

Below are MeSH descriptors whose meaning is related to "Cholinergic Agents".

Below are MeSH descriptors whose meaning is more specific than "Cholinergic Agents".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Cholinergic Agents" by people in this website by year, and whether "Cholinergic Agents" was a major or minor topic of these publications.

Bar chart showing 8 publications over 6 distinct years, with a maximum of 2 publications in 2022 and 2023

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	1	0	1
2006	0	1	1
2020	0	1	1
2022	1	1	2
2023	0	2	2
2024	0	1	1

Below are the most recent publications written about "Cholinergic Agents" by people in Profiles.

Kang WK, Florman JT, Araya A, Fox BW, Thackeray A, Schroeder FC, Walhout AJM, Alkema MJ. Vitamin B12 produced by gut bacteria modulates cholinergic signalling. Nat Cell Biol. 2024 Jan; 26(1):72-85.

View in: PubMed
Chung L, Jing M, Li Y, Tapper AR. Feed-forward Activation of Habenula Cholinergic Neurons by Local Acetylcholine. Neuroscience. 2023 Oct 01; 529:172-182.

View in: PubMed
Nemy M, Dyrba M, Brosseron F, Buerger K, Dechent P, Dobisch L, Ewers M, Fliessbach K, Glanz W, Goerss D, Heneka MT, Hetzer S, Incesoy EI, Janowitz D, Kilimann I, Laske C, Maier F, Munk MH, Perneczky R, Peters O, Preis L, Priller J, Rauchmann BS, R?ske S, Roy N, Scheffler K, Schneider A, Schott BH, Spottke A, Spruth EJ, Wagner M, Wiltfang J, Yakupov R, Eriksdotter M, Westman E, Stepankova O, Vyslouzilova L, D?zel E, Jessen F, Teipel SJ, Ferreira D. Cholinergic white matter pathways along the Alzheimer's disease continuum. Brain. 2023 05 02; 146(5):2075-2088.

View in: PubMed
Sperling SA, Druzgal J, Blair JC, Flanigan JL, Stohlman SL, Barrett MJ. Cholinergic nucleus 4 grey matter density is associated with apathy in Parkinson's disease. Clin Neuropsychol. 2023 04; 37(3):676-694.

View in: PubMed
Teipel SJ, Dyrba M, Ballarini T, Brosseron F, Bruno D, Buerger K, Cosma NC, Dechent P, Dobisch L, D?zel E, Ewers M, Fliessbach K, Haynes JD, Janowitz D, Kilimann I, Laske C, Maier F, Metzger CD, Munk MH, Peters O, Pomara N, Preis L, Priller J, Ram?rez A, Roy N, Scheffler K, Schneider A, Schott BH, Spottke A, Spruth EJ, Wagner M, Wiltfang J, Jessen F, Heneka MT. Association of Cholinergic Basal Forebrain Volume and Functional Connectivity with Markers of Inflammatory Response in the Alzheimer's Disease Spectrum. J Alzheimers Dis. 2022; 85(3):1267-1282.

View in: PubMed
Dalrymple WA, Huss DS, Blair J, Flanigan JL, Patrie J, Sperling SA, Shah BB, Harrison MB, Druzgal TJ, Barrett MJ. Cholinergic nucleus 4 atrophy and gait impairment in Parkinson's disease. J Neurol. 2021 Jan; 268(1):95-101.

View in: PubMed
Lian BQ, Keaney JF. Predicting ischemic heart disease in women: the value of endothelial function. J Am Coll Cardiol. 2010 Apr 20; 55(16):1697-9.

View in: PubMed
Al-Azzawi HH, Mathur A, Lu D, Swartz-Basile DA, Nakeeb A, Pitt HA. Pioglitazone increases gallbladder volume in insulin-resistant obese mice. J Surg Res. 2006 Dec; 136(2):192-7.

View in: PubMed
Madison JM, Yamaguchi H. Muscarinic inhibition of adenylyl cyclase regulates intracellular calcium in single airway smooth muscle cells. Am J Physiol. 1996 Feb; 270(2 Pt 1):L208-14.

View in: PubMed

People

Explore

Similar Concepts

Top Journals